234 related articles for article (PubMed ID: 12107980)
21. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
22. Elevation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis.
Nakayama T; Hashimoto S; Amemiya E; Horie T
Clin Exp Immunol; 1996 May; 104(2):318-24. PubMed ID: 8625527
[TBL] [Abstract][Full Text] [Related]
23. Plasma cytokine parameters and mortality in patients with chronic heart failure.
Rauchhaus M; Doehner W; Francis DP; Davos C; Kemp M; Liebenthal C; Niebauer J; Hooper J; Volk HD; Coats AJ; Anker SD
Circulation; 2000 Dec; 102(25):3060-7. PubMed ID: 11120695
[TBL] [Abstract][Full Text] [Related]
24. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
Kacprzyk F
Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
[TBL] [Abstract][Full Text] [Related]
25. Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.
Limb GA; Soomro H; Janikoun S; Hollifield RD; Shilling J
Clin Exp Immunol; 1999 Mar; 115(3):409-14. PubMed ID: 10193411
[TBL] [Abstract][Full Text] [Related]
26. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
27. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
29. Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis.
Lin SY; Wang YY; Sheu WH
Metabolism; 2004 Jul; 53(7):922-6. PubMed ID: 15254888
[TBL] [Abstract][Full Text] [Related]
30. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
31. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
[TBL] [Abstract][Full Text] [Related]
32. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
Rauchhaus M; Koloczek V; Volk H; Kemp M; Niebauer J; Francis DP; Coats AJ; Anker SD
Int J Cardiol; 2000; 76(2-3):125-33. PubMed ID: 11104867
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
35. Elevation of serum eosinophil cationic protein, soluble tumor necrosis factor receptors and soluble intercellular adhesion molecule-1 levels in acute bronchial asthma.
Kokuludağ A; Sin A; Terzioğlu E; Saydam G; Sebik F
J Investig Allergol Clin Immunol; 2002; 12(3):211-4. PubMed ID: 12530121
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure.
Petretta M; Condorelli GL; Spinelli L; Scopacasa F; de Caterina M; Leosco D; Vicario ML; Bonaduce D
Am Heart J; 2000 Dec; 140(6):E28. PubMed ID: 11100001
[TBL] [Abstract][Full Text] [Related]
37. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
Girardin E; Roux-Lombard P; Grau GE; Suter P; Gallati H; Dayer JM
Immunology; 1992 May; 76(1):20-3. PubMed ID: 1321092
[TBL] [Abstract][Full Text] [Related]
38. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
